Published in J Pediatr Surg on October 01, 1974
Extrahepatic biliary atresia versus neonatal hepatitis. Review of 137 prospectively investigated infants. Arch Dis Child (1976) 2.67
Hepatic portoenterostomy: an assessment of its value in the treatment of biliary atresia. Ann Surg (1975) 0.87
Identification of the jaundiced infant who is likely to recover without surgical intervention. Ann Surg (1976) 0.81
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1991) 3.16
Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology (1972) 2.73
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med (1969) 2.40
The desire for multiple births in couples with infertility problems contradicts present practice patterns. Hum Reprod (1995) 2.17
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation (1993) 2.04
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta (1972) 1.73
Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67
Long-term treatment with human growth hormone (Raben) in small doses. Evaluation of 18 hypopituitary patients. Helv Paediatr Acta (1967) 1.56
The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma. J Clin Oncol (1991) 1.52
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1994) 1.51
Pancreas divisum, pancreatic pseudocyst, and choledochal cyst in an 8-year-old child. J Pediatr Surg (1989) 1.46
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum (1986) 1.39
Degradative effect of phenol on endotoxin and lipopolysaccharide preparations from Serratia marcescens. J Bacteriol (1974) 1.39
The international system of units (si)and medicine. West J Med (1981) 1.39
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
Disturbances in fat digestion induced by acidic jejunal pH due to gastric hypersecretion in man. Gastroenterology (1970) 1.33
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Survival prediction in portacaval shunts: a computerized statistical analysis. Am J Surg (1973) 1.29
Intestinal disaccharidase activities in relation to age, race, and mucosal damage. Gastroenterology (1978) 1.25
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Lipoprotein-X and the double 131 I-rose bengal test in the diagnosis of prolonged infantile jaundice. J Pediatr Surg (1972) 1.21
Hernia survey of the Section on Surgery of the American Academy of Pediatrics. J Pediatr Surg (1996) 1.21
Apoliproproteins and lipoproteins. Atherosclerosis (1971) 1.17
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study. J Pediatr Hematol Oncol (2000) 1.17
Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res (1989) 1.17
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant (1994) 1.17
Excretion of bile acids in normal rabbits. Am J Physiol (1966) 1.15
Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem (1976) 1.15
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation (1994) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett (1973) 1.13
Hepatic portoenterostomy--is it indicated in the treatment of biliary atresia? J Pediatr Surg (1974) 1.13
Hydroxy fatty acids in human diarrhea. Gastroenterology (1972) 1.12
Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry (1970) 1.12
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08. Biochemistry (1973) 1.11
The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group. J Clin Oncol (1994) 1.10
Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol (1988) 1.06
Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta (1976) 1.06
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. J Natl Cancer Inst (1997) 1.05
Pain management in rheumatoid arthritis patients. A cognitive-behavioral approach. Arthritis Rheum (1988) 1.05
Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry (1972) 1.05
Familial congenital diaphragmatic hernia is an autosomal recessive variant. J Pediatr Surg (1989) 1.05
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest (1970) 1.04
Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg (1995) 1.04
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res (1983) 1.03
Studies on the characterization of lipopolysaccharides from two strains of Serratia marcescens. Ann N Y Acad Sci (1966) 1.03
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Nephron (1991) 1.02
Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry (1966) 1.02
Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta (1980) 1.02
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects. Clin Cardiol (1999) 1.02
The efficacy of Thal fundoplication in the treatment of gastroesophageal reflux: the influence of central nervous system impairment. J Pediatr Surg (1988) 1.02
Congenital pancreatic lipase deficiency. J Pediatr (1980) 1.01
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. J Clin Oncol (1998) 1.01
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry (1978) 1.00
The epidemiology of burns. The cause and control of burns in children. Pediatrics (1969) 1.00
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens Bizio. Biochemistry (1973) 0.99
Significance of serum amylase level in evaluating pancreatic trauma. Am J Surg (1975) 0.98
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Biochim Biophys Acta (1987) 0.98
Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem (1978) 0.98
Reduced performance of male and female athletes at 580 m altitude. Eur J Appl Physiol Occup Physiol (1997) 0.97
Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. Biochemistry (1976) 0.97
Increased arterial desaturation in trained cyclists during maximal exercise at 580 m altitude. J Appl Physiol (1985) (1996) 0.96
Role of fat maldigestion in pathogenesis of steatorrhea in ileal resection. Fat digestion after two sequential test meals with and without cholestyramine. Gastroenterology (1976) 0.96
Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate-accentuated lipemia. J Lab Clin Med (1965) 0.95
Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. Eur J Cancer (1997) 0.94
Partial galactose-1-phosphate uridyltransferase deficiency due to a variant enzyme. Helv Paediatr Acta (1967) 0.93
Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta (1977) 0.93
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol (1998) 0.92
Gastroesophageal reflux in childhood. The dilemma of surgical success. Ann Surg (1983) 0.92
David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. Can J Biochem (1981) 0.92
The metabolic effect of a small uniform dose of human growth hormone in hypopituitary dwarfs and in control children. I. Nitrogen, alpha-amino-N, creatine-creatinine and calcium excretion and serum urea-N, alpha-amino-N, inorganic phosphorus and alkaline phosphatase. Acta Endocrinol (Copenh) (1968) 0.92
Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study. Am J Clin Oncol (1992) 0.92
The risk of nephrectomy during local control in abdominal neuroblastoma. J Pediatr Surg (1998) 0.92
Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis (1981) 0.91
Physiocochemical properties of low-density lipoproteins of normal human plasma. Evidence for the occurrence of lipoprotein B in associated and free forms. Biochem J (1974) 0.91
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate. Arterioscler Thromb Vasc Biol (1997) 0.91
Effects of saturated, monounsaturated, and omega-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans. Am J Clin Nutr (1983) 0.91
Plasma lipids and apolipoproteins in a 13-year-old boy with diabetic ketoacidosis and extreme hyperlipidemia. Am J Med Sci (1986) 0.90
Non-traumatic hematuria in children. J Urol (1966) 0.90
Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma. J Pediatr Hematol Oncol (1995) 0.90
Binding and degradation of human high-density lipoproteins by human hepatoma cell line HepG2. Biochim Biophys Acta (1985) 0.90
Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. Clin Chem (1987) 0.89
Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. J Lipid Res (1990) 0.89
Lower esophageal pressure changes with tube gastrostomy: a causative factor of gastroesophageal reflux in children? J Pediatr Surg (1986) 0.89
Protective antireflux operation with feeding gastrostomy. Experience with children. Ann Surg (1985) 0.89
Gastric emptying in children with gastroesophageal reflux. II. The relationship to retching symptoms following antireflux surgery. J Pediatr Surg (1987) 0.89